The president of the Canadian Federation of Independent Business is questioning Canada’s new round of COVID-19 restrictions put in place to stop the rapid spread of the Omicron variant, despite reports that the variant causes less severe illness than its predecessors.
“If #omicron continues to result in very few admissions to hospitals/ICUs, how long will it be before provinces remove their new restrictions and lessen the panic they’ve created. U.S. public health officials say there is no need to close schools or businesses,” Dan Kelly, who is also the chief executive officer and chair of the business advocacy group, wrote on Twitter.
If #omicron continues to result in very few admissions to hospitals/ICUs, how long will it be before provinces remove their new restrictions & lessen the panic they’ve created. US public health officials say there is no need to close schools or businesses.— Dan Kelly (@CFIB) December 23, 2021
Kelly’s comment comes after Ontario’s top doctor said Dec. 21 that there haven’t been any known intensive care admissions in the province due to Omicron—nearly a month after Canada’s first two cases of the new variant were detected in Ottawa on Nov. 28.
Omicron’s hospitalization rate in Ontario was around 0.15 percent as of Dec. 21—significantly lower than the province’s general COVID-19 hospitalization rate, said Dr. Kieran Moore, Ontario’s chief medical officer of health.
Similar findings were reported around the world.
The UK Health Security Agency said on Dec. 23 that a person infected with Omicron is 70 percent less likely to be admitted to the hospital compared to one with the Delta variant, and is 45 percent less likely to require a visit to the emergency department.
The risk of hospitalization due to Omicron was estimated to be 80 percent lower than with the Delta variant, according to a recent study conducted by the National Institute for Communicable Diseases and major universities in South Africa.
As the latest variant of concern, Omicron was found to be more transmissible than previous COVID-19 variants, probably because it multiplies more rapidly—replicating 70 times faster than the Delta variant—according to a study conducted by the University of Hong Kong.
The study also found that Omicron multiplies more in the respiratory tract, which likely explains why it causes significantly lower infection in the lung than the original SARS-CoV-2.
However, government and public health officials have called for further restrictions and mass vaccinations in response to Omicron.
On Dec. 23, the Quebec government tightened public health restrictions for the third time in less than a week, limiting in-person gatherings to six people starting Dec. 26, while gyms, bars, and schools in the province were abruptly closed following a Dec. 20 announcement.
Other provinces and territories also released tougher COVID-19 restrictions on Dec. 21, including British Columbia, New Brunswick, and Nova Scotia.
In a statement issued Dec. 23, the Public Health Agency of Canada (PHAC) urged Canadians to reduce social contacts and receive a vaccine booster shot.
As of Dec. 22, there have been 3,536 confirmed cases of the Omicron variant, reported in 12 provinces and territories, according to PHAC.
While PHAC’s statement said Omicron cases are “expected to add additional strain on the healthcare system” in coming weeks and that the increased hospitalization and critical care admission in Ontario and Quebec are “driving the national trend,” it did not mention the exact numbers of intensive care admissions caused by the variant.
Monkeypox cases are rising. Should we be worried?
The World Health Organization has said the current outbreak of monkeypox is the largest ever recorded outside sub-Saharan
The post Monkeypox cases are…
The World Health Organization has said the current outbreak of monkeypox is the largest ever recorded outside sub-Saharan Africa, with cases rising above the 100-mark a few days ago and the UK top of the table with 56 as of yesterday.
Top of the list of concerns is how the virus – which does not spread easily between humans and requires skin-to-skin contact – is spreading so quickly in so many countries in Europe, the Americas and Australia where the disease is not endemic.
There is speculation that monkeypox may be being spread between sexual partners, even though it is not normally considered a sexually-transmitted infection. Thankfully, there have been no deaths reported so far, although the WHO notes monkeypox has a fatality rate of between 3% and 6%.
While health authorities are on alert, the WHO said it thinks the outbreak can be contained and that the overall risk to the population remains low. It also stressed there is no evidence that a viral mutation is responsible for the unusual pattern of infections.
Monkeypox is considered less likely to mutate quickly because it is a DNA virus rather than an RNA virus like influenza or COVID-19.
Several countries including Belgium and the UK are already advising a three-week quarantine period for anyone who contracts the virus and their close contacts.
The increasing case numbers in the current monkeypox outbreak are certainly concerning,” commented Dr Charlotte Hammer, an expert in emerging infectious diseases based at the University of Cambridge in the UK.
“It is very unusual to see community transmission in Europe – previous monkeypox cases have been in returning travellers with limited ongoing spread. However, based on the number of cases that were already discovered across Europe and the UK in the previous days, it is not unexpected that additional cases are now being and will be found, especially with the contact tracing that is now happening.”
Vaccines and drugs are available
Meanwhile, attention is now being turned to other measures to control the outbreak, including the use of vaccines against smallpox – a related virus – in a ‘ring vaccination’ approach designed to control the spread among contacts.
Vaccines used during the smallpox eradication programme can provide around 85% protection against monkeypox, according to the WHO, which notes that one newer vaccine – Bavarian Nordic’s Jyneos – has been approved by the FDA for prevention against both viruses.
There’s also a licensed antiviral drug for monkeypox. SIGA Technologies’ oral drug Tpoxx (tecovirimat) is approved for smallpox, monkeypox and cowpox in Europe, and in the US and Canada for smallpox, although it can be used off-label for the other disease. The US FDA also approved a new intravenous form of the drug last week.
The WHO says there is no need for widespread vaccination, as other control measures like isolation of patients should be enough to curb the spread and in any case supplies of vaccines are limited.
Monkeypox causes symptoms similar to but milder than smallpox, typically beginning with fever, headache, muscle aches and exhaustion. It is transmitted to people from various wild animals, such as rodents and primates, and is usually a self-limited disease with symptoms lasting from two to four weeks.
In 2003, the US experienced an outbreak of monkeypox, which was the first time human monkeypox was reported outside of Africa. The Centers for Disease Control and Prevention (CDC) is making some Jyneos vaccine reserves available for close contact inoculations, including healthcare workers tending to patients.
The UK Health Security Agency (UKHSA) said yesterday it had identified 36 additional cases of monkeypox in England, and that vaccination of high-risk contacts of cases is already underway.
“A notable proportion of recent cases in the UK and Europe have been found in gay and bisexual men so we are particularly encouraging these men to be alert to the symptoms,” said the agency’s chief medical advisor Dr Susan Hopkins.
“Because the virus spreads through close contact, we are urging everyone to be aware of any unusual rashes or lesions and to contact a sexual health service if they have any symptoms.”
The post Monkeypox cases are rising. Should we be worried? appeared first on .cdc disease control covid-19 vaccine fda rna dna spread deaths quarantine transmission africa canada europe uk world health organization
What does good cybersecurity look like in 2022?
The pharma industry is becoming an increasingly hot commodity for cybercriminals. In recent years, digital adoption has accelerated
The post What does…
The pharma industry is becoming an increasingly hot commodity for cybercriminals. In recent years, digital adoption has accelerated at a rapid pace, with companies racing to integrate cloud-based platforms and telehealth services to expand the delivery of modern healthcare. Combined with the sudden arrival of COVID-19, this perfect storm of events handed cybercriminals an opportunity to exploit weaknesses in fledging systems and processes.
Pharma companies hold masses of vital data sets, from classified intellectual property to proprietary information about drugs and clinical trial developments. The value of such data is not lost on cybercriminals. This was illustrated in 2021, amid growing awareness of the pharma industries’ efforts to develop and distribute COVID-19 vaccines. According to cybersecurity firm Critical Insights, the number of cybersecurity breaches in healthcare reached an all-time high in 2021, exposing an unprecedented amount of protected health information.
Cyber attacks can be highly damaging, both financially and to a company’s reputation. Therefore, it is essential that necessary steps are taken, both at a company and individual level, to understand and prevent the risk of cyber threats. But what does good cybersecurity actually look like? To help navigate the complex world of digital crime, Adarma’s threat consultant Mike Varley, KnowBe4 lead security awareness advocate Javvad Malik, CEO and founder of CyberSmart Jamie Akhtar, and senior engineer at Trend Micro Simon Walsh offer their insights into key trends and best practises for pharma companies.
Why is the healthcare industry a particular target for cyberattacks?
Javvad Malik (JM): Historically cybercriminals were after money, so they often ignored healthcare providers. However, with increasing sophistication within the criminal economies and the ability to monetise data through ransomware, other means of extortion, or resale, healthcare providers have become an almost ideal target for criminals.
Simon Walsh (SW): Despite statements from would-be attackers to the contrary, the healthcare and pharma industries became prime targets during the COVID pandemic, particularly for ransomware operators, as we saw during the breach of the Irish Healthcare Service Executive in May 2021.
There are several reasons for this: they’re seen as easy targets because of their relative lack of security maturity; the COVID pandemic-induced strain they’re already under makes them more likely to pay the ransom; and the fact that the data they hold – patient records – is extremely valuable and opens additional paths to extortion.
Jamie Akhtar (JA): Many healthcare providers have weak or limited defences. These range from poor staff awareness of threats to creaking, outdated operating systems and tech, but whatever the reason, cybercriminals are aware that many healthcare providers make for easy pickings.
Mike Varley (MV): We can expect to see a rising number of ransomware attacks on the healthcare sector. Healthcare is recognised as national critical infrastructure, which makes it an attractive target to malicious foreign entities looking to create chaos and harm. Similarly, when human life is put at risk by an attack, organisations are more likely to pay up, so attackers often view these structures as a quick pay-day.
Where do you see the most mistakes being made in healthcare when it comes to addressing cyber threats?
JM: Perhaps the biggest mistakes or challenges healthcare faces when addressing cyber threats are having outdated or unpatched software running, being too quick to purchase or adopt internet-connected devices without demanding rigorous security testing, and, finally, the lack of security awareness and training amongst IT staff.
SW: Security maturity and the ability to successfully detect and withstand attacks comes from understanding cyber risk and building and developing a cyber security strategy around that understanding. This of course needs to be adopted and driven by the board and C-level executives and too often this is not the case, with a lack of understanding and investment resulting in a weakened security posture.
Over-reliance on security technology without adequate human oversight further weakens this posture. The Irish hospitals who successfully prevented the attack in May 2021 were those who not just detected stages of the attack but also understood what those detections meant and acted as a result.
Developing a human oversight function – for example a Security Operations Centre – in house is costly, difficult, and takes time. So, for many in the healthcare/pharma industry, the quickest route to success on this front is working with the correct partner who will provide that function.
JA: There are two areas in which most organisations, not just healthcare providers, could be doing better. Many aren’t doing the simple things that can thwart most cyber-attacks. For example, regularly updating software and operating systems, using strong passwords and MFA, developing clear policies for staff to follow, and ensuring security tools are configured properly.
On top of this, employee awareness of cyber threats just isn’t widespread enough. An organisation can have the best cybersecurity software around but, if an employee doesn’t know what a phishing email looks like and clicks a malicious link, it’ll be hacked just the same. The way to counter this is basic cybersecurity training. It doesn’t have to be comprehensive, just enough to help your people make informed choices.
What trends are you seeing in cybersecurity at the moment?
JA: The most worrying trend is the rise in supply chain attacks. Cybercriminals have worked out that the best way to target large enterprises with solid defences, is to attack a smaller, less well-defended supplier who can give them a backdoor in. As a result, we’re seeing more major attacks originate in this way.
Alongside this, phishing continues to be the single most common form of attack. Due to the general lack of awareness in the working population, many organisations are still struggling to contain the threat.
MV: Increasingly I think we will see healthcare sector organisations turning to managed security service providers who have the expertise, capability, and technology to deal with an increasingly complex and harmful cyber landscape.
The healthcare sector is expected to provide an elevated level of cyber protection and with a shortage of cyber talent and the prohibitive cost of establishing a Security Operations Centre internally, organisations will need a trusted security partner that can provide that level of proactive protection.
What advice would you give to companies looking to improve their cybersecurity policies, both on a company-wide scale and individual basis?
JA: Above all, make them clear and easy to follow. Avoid technical jargon, where possible, as this will only disengage people. And, explain why the company has adopted the policies it has; your staff will find it much easier to follow them if they know why. Also, store them somewhere that’s easy to access from anywhere. There’s little use in a policy if it’s buried deep in a shared drive where nobody reads it.
MV: Cybersecurity policies should be informed by a threat-led approach. Regular threat modelling will highlight what threats you are facing and how adversaries are likely to target your organisation. With this information on areas of commonality, your security teams can focus on implementing layered security and monitoring.
Your policy should consider asset awareness. As basic as it sounds, it can be easy for a small handful of assets to fall under the radar within vast enterprises, which leads to out-of-date operating systems and software.
JM: Organisations should look to take a data-driven approach. That means, that in addition to following what is occurring externally in terms of attacks, they should look through a year or two worth of internal security logs to see what was the root cause of the incidents during this time period.
Once the root causes have been identified, they should be prioritised, and then controls be put in place to address those specific root causes. Those should inform the cybersecurity policies and tailor them to the specific risks the organisation is facing.
SW: For companies, start at the top and ensure that the board and C-level executives are capable of understanding and assessing risk. This will drive investment in cyber strategy and improve your chances of mitigating that risk. Human oversight of security-related activity in the organisation is also fundamental.
For individuals, heightened awareness and ongoing education are key. We all have a role to play in cyber-security as 100% reliance on technology is unfortunately never enough.
The post What does good cybersecurity look like in 2022? appeared first on .link pandemic covid-19 testing
CDC Now Recommends COVID Testing For All Domestic Air Travel, Including The Vaccinated
CDC Now Recommends COVID Testing For All Domestic Air Travel, Including The Vaccinated
Authored by Jack Phillips via The Epoch Times,
In an update on the agency’s website, anyone traveling within the United States may want to consider “getting tested as close to the time of departure as possible,” and no more than three days before a flight. It previously only recommended testing for people who have not received COVID-19 vaccines or up-to-date booster shots.
The CDC update is also recommending that people take a test before or after a trip if they went to crowded spaces “while not wearing a well-fitting mask or respirator.”
In April, a Florida federal judge struck down the CDC mandate that required people to wear masks inside airports or on airplanes. Justice Department officials have signaled they will challenge the rule, implemented after President Joe Biden took office in early 2021, in court.
A spokesperson for the agency told AFAR Magazine on May 19 that “COVID-19 vaccines are effective at preventing severe disease and death,” but added, “since vaccines are not 100 percent effective at preventing infection, some people who are up to date can still get COVID-19.”
“People who are up to date with their COVID-19 vaccines may feel well and not have symptoms but still can be infected and spread the virus to others,” the spokesperson said.
In January of this year, the CDC also implemented a change to its international travel rule, requiring plane passengers aged 2 and older to show a negative COVID-19 test from no more than a day before boarding a flight or proof of recovery from COVID-19 within the previous 90 days. Foreign nationals have to show proof of COVID-19 vaccination as well.
Neither the CDC nor the White House has given any public indication of when the mandatory testing rule for international travelers will be relaxed. Travel groups have pushed for that rule to be removed for months now.
In a letter to the White House, a group representing more than 250 organizations called for an end to the rule, saying it’s only caused “slow economic recovery of the business and international travel sectors.”
After the federal judge’s order was handed down last month, the CDC issued a new recommendation that people inside airports and airplanes wear masks, despite nearly all major airliners having scrapped enforcement.
And during a news briefing last week, CDC Director Rochelle Walensky, who has been criticized for her agency’s messaging during the COVID-19 pandemic, said that people living in counties that the agency deems to have high COVID-19 transmission should wear masks in indoor settings.
Everything You Want To Know About Monkeypox, But Were Afraid To Ask
National Poll: Safety not always top of mind for parents choosing kids’ summer camps
Bullwhip Effect Ends With A Bang: Why Prices Are About To Fall Off A Cliff
Bloated Inventories Hit Walmart, Target And Other Retailers’ Profits, Trucking Demand
Why We Must Resist Geoeconomic Fragmentation—And How
Georgia’s Record-Breaking Early Voting Turnout Defies “Voter Suppression” Accusations
The Monkeypox Virus: What You Need To Know
Top Stock Market News For Today May 23, 2022
How This Ends
When Will Royal Caribbean, Carnival, Norwegian Drop Covid Tests, Vaccine Rule?
Economics5 hours ago
U.S. Experienced Highest Ever Combined Rates of Deaths Due to Alcohol, Drugs, and Suicide During the COVID-19 Pandemic
Economics20 hours ago
QBE North America Provides Tips to Help Businesses Prepare for Hurricane Season
Economics9 hours ago
Municipal Water and Wastewater Treatment Equipment Market Size to Increase by USD 16.02 Billion from 2021 to 2026| Technavio
International10 hours ago
Formula Shortage Highlights Supply Chain Concerns Facing Pharma Industry
International15 hours ago
Dr. Roger Härtl named AANS Humanitarian of the Year
Stocks23 hours ago
Americans Have Lost $20 Trillion Since The Start Of 2022
Government12 hours ago
CDC Now Recommends COVID Testing For All Domestic Air Travel, Including The Vaccinated
Government14 hours ago
Royal Caribbean, Carnival Cruise Lines Hit a Pandemic Comeback Milestone